Breakpoint’s Managing Directors Daniel Speidel and Jon Hollick will attend the DDR Inhibitors Summit 2024 in Boston (30 January- 1 February 2024). At this international meeting, experts from industry and academia gather to share and discuss updates in the development of novel therapeutics targeting the DNA Damage response in cancer cells. Daniel Speidel will chair […]
https://breakpointtx.com/wp-content/uploads/2022/12/BreakpointTx_Logo_RGB.svg00dSpeidelhttps://breakpointtx.com/wp-content/uploads/2022/12/BreakpointTx_Logo_RGB.svgdSpeidel2024-01-30 21:21:392024-01-30 21:22:35Breakpoint To Chair and Present at DDR Inhibitors Summit 2024
Breakpoint’s Managing Director Daniel Speidel will present a company overview during JPM at Biotech Showcase in San Francisco on January 9, 2024. Hilton Union Square 2:15 pm, Franciscan C.
https://breakpointtx.com/wp-content/uploads/2022/12/BreakpointTx_Logo_RGB.svg00dSpeidelhttps://breakpointtx.com/wp-content/uploads/2022/12/BreakpointTx_Logo_RGB.svgdSpeidel2024-01-04 11:13:492024-01-04 11:14:00Breakpoint To Present At Biotech Showcase
Breakpoint’s Managing Director Jon Hollick will present a talk entitled “Decoding DNA Damage Response (DDR) Efficacy in Tumour Models to Advance Translation into the Clinic” at the 12th Annual Tumour Models London Summit (06-07 December 2023). He will also participate in the opening plenary panel discussing “How Do You Select the Best Model for Your […]
https://breakpointtx.com/wp-content/uploads/2022/12/BreakpointTx_Logo_RGB.svg00dSpeidelhttps://breakpointtx.com/wp-content/uploads/2022/12/BreakpointTx_Logo_RGB.svgdSpeidel2023-11-30 17:31:372023-11-30 17:34:37Breakpoint to Present At Tumour Models London Summit
Breakpoint To Chair and Present at DDR Inhibitors Summit 2024
Breakpoint’s Managing Directors Daniel Speidel and Jon Hollick will attend the DDR Inhibitors Summit 2024 in Boston (30 January- 1 February 2024). At this international meeting, experts from industry and academia gather to share and discuss updates in the development of novel therapeutics targeting the DNA Damage response in cancer cells. Daniel Speidel will chair […]
Breakpoint To Present At Biotech Showcase
Breakpoint’s Managing Director Daniel Speidel will present a company overview during JPM at Biotech Showcase in San Francisco on January 9, 2024. Hilton Union Square 2:15 pm, Franciscan C.
Breakpoint to Present At Tumour Models London Summit
Breakpoint’s Managing Director Jon Hollick will present a talk entitled “Decoding DNA Damage Response (DDR) Efficacy in Tumour Models to Advance Translation into the Clinic” at the 12th Annual Tumour Models London Summit (06-07 December 2023). He will also participate in the opening plenary panel discussing “How Do You Select the Best Model for Your […]